Researchers dig into Real-World data to see how a kidney drug works in india
NCT ID NCT06763146
Summary
This study aims to learn more about how the drug finerenone works for people in India who have chronic kidney disease and type 2 diabetes. Researchers will look back at the medical records of about 1,200 patients who were already prescribed this approved medication. The goal is to understand treatment patterns, safety, and how well the drug controlled kidney damage in this specific population.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many locations
Multiple Locations, India
Conditions
Explore the condition pages connected to this study.